Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years

Documenti analoghi

• Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone Mice
  di: Oaks, Zachary, et al.
  Pubblicazione: (2016)
• Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases
  di: Perl, Andras
  Pubblicazione: (2015)
• Optimal infusion rate in antimicrobial therapy explosion of evidence in the last five years
  di: Zhu, Ling-ling, et al.
  Pubblicazione: (2018)
• NINE-TEST PANEL HAS SUPERIOR SENSITIVITY TO DETECT ANTIPHOSPHOLIPID ANTIBODY SYNDROME IN PATIENTS WITH OR WITHOUT SLE
  di: Dziamski, Konrad, et al.
  Pubblicazione: (2020)
• Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin
  di: Perl, Andras, et al.
  Pubblicazione: (2015)